[Blood glucose control in type 2 diabetes. Basic requirements for reducing vascular complications]

Area of Science:

• Endocrinology
• Cardiology
• Metabolic Syndrome Research

Background:

• Type 2 diabetes (T2D) significantly elevates risks for microvascular and macrovascular complications.
• Postprandial hyperglycemia is a key contributor to atherosclerosis and increased cardiovascular risk in T2D patients.
• Current clinical practice often falls short of implementing national recommendations for T2D management.

Purpose of the Study:

• To underscore the necessity of early, multifactorial interventions for metabolic syndrome in T2D.
• To highlight the proatherogenic impact of postprandial hyperglycemia and its link to cardiovascular risk.
• To advocate for individualized antidiabetic therapy and improved adherence to clinical guidelines.

Main Methods:

• Review of epidemiological data on postprandial hyperglycemia and cardiovascular risk.
• Analysis of therapeutic goals for intensive blood glucose control (preprandial <110 mg/dl, postprandial <140 mg/dl).
• Consideration of patient self-management capabilities in treatment selection.

Main Results:

• Postprandial hyperglycemia demonstrates significant proatherogenic effects, escalating overall cardiovascular risk.
• Intensive glycemic control is essential for mitigating the incidence of diabetic complications.
• Individualized therapy selection, considering patient self-management, is paramount.

Conclusions:

• Early and multifactorial interventions are vital for managing type 2 diabetes and its complications.
• Strict blood glucose control, particularly postprandial levels, is necessary to reduce cardiovascular risk.
• Enhanced implementation of national T2D treatment guidelines and patient-centered care are critical for improving outcomes.